Company Registration No. 10583623 (England and Wales)
Cancertain Limited
Unaudited accounts
for the period from 1 February 2024 to 31 March 2025
Cancertain Limited
Unaudited accounts
Contents
Cancertain Limited
Company Information
for the period from 1 February 2024 to 31 March 2025
Directors
David Mark Whitcombe
DR Gopala Krishna Babu Pureti
Dharmesh Metha
Zalakben Himanshu Kataria
DR Himanshu Laxmidas Kataria
Company Number
10583623 (England and Wales)
Registered Office
222 Kingsway
Gatley
Cheadle
Cheshire
SK8 4PB
England
Accountants
Emerald Path Ltd
32 Frances Avenue
Gatley
Cheadle
Cheshire
SK8 4BJ
Cancertain Limited
Statement of financial position
as at 31 March 2025
Tangible assets
1,809
13,909
Cash at bank and in hand
29,790
33,638
Creditors: amounts falling due within one year
(27,981)
(6,771)
Net current assets
207,907
232,380
Total assets less current liabilities
219,493
246,408
Creditors: amounts falling due after more than one year
(40,573)
-
Net assets
178,920
246,408
Called up share capital
41
41
Share premium
1,392,423
1,392,423
Profit and loss account
(1,213,544)
(1,146,056)
Shareholders' funds
178,920
246,408
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 17 October 2026 and were signed on its behalf by
DR Himanshu Laxmidas Kataria
Director
Company Registration No. 10583623
Cancertain Limited
Notes to the Accounts
for the period from 1 February 2024 to 31 March 2025
Cancertain Limited is a private company, limited by shares, registered in England and Wales, registration number 10583623. The registered office is 222 Kingsway, Gatley, Cheadle, Cheshire, SK8 4PB, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
15 % Straight Line
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Expenditure on research and development is written off in the year in which it is incurred.
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
Cancertain Limited
Notes to the Accounts
for the period from 1 February 2024 to 31 March 2025
4
Intangible fixed assets
Other
Intangible Assets relates to IP – Patents & Trade Marks
5
Tangible fixed assets
Plant & machinery
Charge for the period
12,100
6
Investments
Other investments
Valuation at 1 February 2024
119
Valuation at 31 March 2025
119
Details of the investments in which the company hold 99.99% or more of the
nominal value of any class of shares capital are as follow:
Clyz Labs (India) Private Ltd Ordinary shares 99.99% Reseach and
exprimental development on biotechnology
Investments in subsidiaries are not listed and held at costs less impairment as
fair value can not be reliably measured.
Cancertain Limited
Notes to the Accounts
for the period from 1 February 2024 to 31 March 2025
Amounts falling due within one year
Amounts due from group undertakings etc.
201,210
201,210
8
Creditors: amounts falling due within one year
2025
2024
Taxes and social security
51
(22,638)
Other creditors
27,804
27,804
Loans from directors
7,159
7,159
9
Creditors: amounts falling due after more than one year
2025
2024
10
Average number of employees
During the period the average number of employees was 1 (2024: 7).